The findings showed that the risk of digestive system cancers including oesophageal, stomach, colon, pancreatic, and liver, ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

The findings highlight mixed trends in death and incidence rates across cancer types and based on race, ethnicity, and sex ...

Cold” tumors are resistant to common immunotherapies. Stanford Medicine researchers have uncovered a master regulator that ...

When experts recommend the best diets for healthy aging, heart health, or to help prevent cancer and chronic disease, they ...

Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical modelsAnti-IL1RAP ADC targets IL1RAP, which is overexpressed in many tumors and their tumor ...

All posters will be available on the ‘Posters and Publications’ page of Cogent’s website. New Leadership Appointments Cogent also announced today that Ray Frost has joined Cogent as Senior Vice ...

NovoCure Limited’s NVCR share price has surged by 7.54%, which has investors questioning if this is right time to sell.

Everyone in the room stood when asked if they had cancer or lost a loved one, friend, or neighbor to the deadly disease.